LOS ANGELES: T3D Therapeutics, Inc., a Research Triangle Park, NC-based developer of Alzheimer’s disease therapies, announced today that the Division of Neurology Products of the U.S. Food and Drug Administration has approved the company’s Investigational New Drug (IND) application to begin a Phase 2a clinical study Read More »
T3D Therapeutics Inc. receives FDA IND approval to begin phase 2 clinical study of T3D-959 in Alzheimer’s patients
Seniors housing developers compete for Global Award
NEW YORK: The six hundred and sixty-eighth entry for the seniors housing Global Awards for 2015 has been received.
A residential complex is to be built near Hereford.
Up to 80 one, two and three-bed apartments are earmarked for the proposed development in Withington, likely to Read More »
Business partners create housing for aging family members
WASHINGTON, D.C.: Childhood friends Jesse Lammi and John Louiselle have founded NextDoor Housing to help aging family members stay close to home.
NextDoor Drop Homes are designed to be alternative housing for seniors.
Louiselle said he and Lammi are from strong-knit families, and Lammi’s grandpa could Read More »
Age care compounds becoming soft crime targets
MIAMI: Retirement communities and skilled nursing homes imply a level of elevated safety in their commercial pitch to prospective customers.
But evidence is mounting that age-apartheid compounds are increasingly becoming soft crime targets and the care sector is trashing its reputation by doing nothing to effectively Read More »